Blood-aqueous Barrier Integrity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular AMD

Clinical trial NCT03744806 · COMPLETED

Trial details

NCT number: NCT03744806
Sponsor: Medical University of Lublin
Status: COMPLETED
Study type: OBSERVATIONAL

Exudative Age-related Macular Degeneration

Start date: 2015-01-01
Primary completion: 2015-09-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.